TE_27627
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluYk3 |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 173.57 |
| Counts of samples | TCGA_tumor:307; TCGA_normal:1; GTEx:0 |
| TSS | chr14(+):43812360 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_27627.21 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43850214,43850261,43910948,43911136,43913731,43913855,43926549,43926616,43929557,43929577 |
| teRNA_27627.22 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43850214,43850261,43913731,43913855,43929557,43929577 |
| teRNA_27627.23 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43850214,43850261,43910948,43911252,43913731,43913855,43926549,43926616,43928420,43928440 |
| teRNA_27627.24 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43827536,43827556 |
| teRNA_27627.25 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43819746,43819766 |
| teRNA_27627.26 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43820699,43820719 |
| teRNA_27627.27 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43819178,43819198 |
| teRNA_27627.28 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43819178,43819215,43821716,43821862,43850214,43850234 |
| teRNA_27627.29 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43859868,43860003,43860808,43860828 |
| teRNA_27627.30 | - | Intergenic | Non-coding | Non-coding | chr14(+):43812361,43812672,43858207,43858286,43859868,43860003,43860808,43860828 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
